Thymogen vs Thymulin
Comparison of Thymogen (Moderate evidence) and Thymulin (Moderate evidence).
Last updated: February 12, 2026
Thymogen
Thymulin
Overview
Thymogen and Thymulin are both studied in the peptide research space.
Thymogen: A synthetic dipeptide (glutamyl-tryptophan) developed in Russia as a defined successor to thymalin.
Thymulin: A zinc-dependent nonapeptide hormone produced by thymic epithelial cells, discovered in 1977.
Evidence Comparison
| Aspect | Thymogen | Thymulin |
|---|---|---|
| Evidence Level | Moderate | Moderate |
| Human Studies | 6 | 8 |
| Preclinical Studies | 19 | 37 |
| Total Sources | 25 | 45 |
Key Differences
| Aspect | Thymogen | Thymulin |
|---|---|---|
| Category | Immune | Immune |
| Evidence Strength | Moderate | Moderate |
| Total Sources | 25 | 45 |
| Human Studies | 6 | 8 |
Summary
- Thymogen: Moderate evidence with 25 total sources (6 human)
- Thymulin: Moderate evidence with 45 total sources (8 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.